BR112012012484A2 - "sais de amina orgânicos de azilsartan, método de preparação e uso dos mesmos". - Google Patents

"sais de amina orgânicos de azilsartan, método de preparação e uso dos mesmos".

Info

Publication number
BR112012012484A2
BR112012012484A2 BR112012012484A BR112012012484A BR112012012484A2 BR 112012012484 A2 BR112012012484 A2 BR 112012012484A2 BR 112012012484 A BR112012012484 A BR 112012012484A BR 112012012484 A BR112012012484 A BR 112012012484A BR 112012012484 A2 BR112012012484 A2 BR 112012012484A2
Authority
BR
Brazil
Prior art keywords
azilsartan
preparation
organic amine
amine salts
machines
Prior art date
Application number
BR112012012484A
Other languages
English (en)
Portuguese (pt)
Inventor
Aifeng Lu
Original Assignee
Jiangsu Hansoh Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hansoh Pharmaceutical filed Critical Jiangsu Hansoh Pharmaceutical
Publication of BR112012012484A2 publication Critical patent/BR112012012484A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR112012012484A 2009-11-30 2010-11-29 "sais de amina orgânicos de azilsartan, método de preparação e uso dos mesmos". BR112012012484A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910246554 2009-11-30
PCT/CN2010/079222 WO2011063764A1 (zh) 2009-11-30 2010-11-29 阿齐沙坦有机胺盐及其制备方法和用途

Publications (1)

Publication Number Publication Date
BR112012012484A2 true BR112012012484A2 (pt) 2016-04-12

Family

ID=44065877

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012012484A BR112012012484A2 (pt) 2009-11-30 2010-11-29 "sais de amina orgânicos de azilsartan, método de preparação e uso dos mesmos".

Country Status (11)

Country Link
US (1) US20120238606A1 (enExample)
EP (1) EP2508522A4 (enExample)
JP (1) JP2013512199A (enExample)
CN (1) CN102548988B (enExample)
AU (1) AU2010324249B2 (enExample)
BR (1) BR112012012484A2 (enExample)
CA (1) CA2782224A1 (enExample)
MX (1) MX2012005776A (enExample)
RU (1) RU2554947C2 (enExample)
WO (1) WO2011063764A1 (enExample)
ZA (1) ZA201202683B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2666773B1 (en) * 2011-01-20 2017-07-26 Jiangsu Hansoh Pharmaceutical Co., Ltd. Organic amine salts of azilsartan, preparation method and use thereof
JP2014530805A (ja) 2011-09-30 2014-11-20 スンシネ ルアケ プハルマ カンパニー リミテッド アジルサルタンの結晶形並びにその製造及び使用
JP2017036215A (ja) * 2013-12-27 2017-02-16 トーアエイヨー株式会社 アンジオテンシンii受容体拮抗物質の塩
CN105037341B (zh) * 2014-04-04 2019-12-03 江苏豪森药业集团有限公司 阿齐沙坦醇铵晶型及其制备方法
CN105503848A (zh) * 2014-10-13 2016-04-20 江苏豪森药业集团有限公司 阿齐沙坦有机胺盐复合物及其制备方法和用途
CZ2014702A3 (cs) 2014-10-15 2016-04-27 Zentiva, K.S. Způsob přípravy vysoce čistého azilsartanu
KR102220011B1 (ko) * 2020-05-15 2021-02-25 대봉엘에스 주식회사 친환경 용매를 이용한 아질사탄의 제조방법 및 이에 관한 핵심 중간체 화합물
KR102862852B1 (ko) * 2022-09-19 2025-09-22 대봉엘에스 주식회사 안지오텐신 ⅱ 길항제로서의 아질사르탄 디시클로헥실아민 및 이를 유효성분으로 하는 심혈관질환 치료 또는 예방용 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924666B (en) * 1991-06-27 1993-12-24 Takeda Chemical Industries Ltd Heterocyclic compounds, their production and use
TW251288B (enExample) * 1991-06-27 1995-07-11 Takeda Dharm Industry Co Ltd
EP1389114A2 (en) * 2001-03-08 2004-02-18 Merck & Co., Inc. Antihypertensive agent and cholesterol absorption inhibitor combination therapy
WO2003047573A1 (en) * 2001-12-03 2003-06-12 Takeda Chemical Industries, Ltd. Insulin resistance improving agents
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
CN101035524A (zh) * 2004-10-07 2007-09-12 武田药品工业株式会社 预防或治疗代谢综合征的药剂
US20070270477A1 (en) * 2004-10-07 2007-11-22 Takeda Pharmaceutical Company Limited Agent for Prophylaxis or Treatment of Metabolic Syndrome
JP2008524186A (ja) * 2004-12-17 2008-07-10 アストラゼネカ・アクチエボラーグ ケモカイン受容体活性の調節のためのチアゾロピラミジン化合物

Also Published As

Publication number Publication date
AU2010324249A1 (en) 2012-05-03
AU2010324249B2 (en) 2014-08-28
HK1164310A1 (en) 2012-09-21
CA2782224A1 (en) 2011-06-03
CN102548988A (zh) 2012-07-04
MX2012005776A (es) 2012-06-13
US20120238606A1 (en) 2012-09-20
RU2012124332A (ru) 2014-01-10
CN102548988B (zh) 2013-10-23
JP2013512199A (ja) 2013-04-11
ZA201202683B (en) 2013-08-28
WO2011063764A1 (zh) 2011-06-03
EP2508522A4 (en) 2013-05-08
RU2554947C2 (ru) 2015-07-10
EP2508522A1 (en) 2012-10-10

Similar Documents

Publication Publication Date Title
BR112012012484A2 (pt) "sais de amina orgânicos de azilsartan, método de preparação e uso dos mesmos".
BR112014007193A2 (pt) derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos
BR112012029872A2 (pt) sistema de direção e aparelho de controle de direção
BR112014004828A2 (pt) método para preparação de uma composição compreendendo anticorpos altamente concentrados por ultrafiltração
BR112013011593A2 (pt) cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo
BRPI0713190A2 (pt) método para a preparação de um composto
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
BR112017009252A2 (pt) solução de nicotina, sistema eletrônico de fornecimento de vapor, processo para melhorar as propriedades sensoriais de uma solução de nicotina vaporizada e uso de um ou mais ácidos
BR112014022178A2 (pt) reparo sem nó baseado em sutura
BR112012006912A8 (pt) Hipervesiculação de cepas de shigella
BRPI0706398B8 (pt) 6-(aril polissubstituído)-4-aminopicolinatos, composição herbicida, e método para controle de vegetação indesejável
BR112014003079A2 (pt) derivado de 1,2,3,4-tetra-hidroquinolina útil para o tratamento de diabetes
BR112014005775A2 (pt) aparelhos e processos para produção em grande escala de fibras híbridas contendo nanoestruturas de carbono e materiais relacionados
AR110128A2 (es) Compuesto del grupo de las 3-(imidazoil)-pirazolo[3,4-b]piridinas, composición farmacéutica que lo comprende y método para preparar el mismo
BRPI1010970A2 (pt) solução farmacêutica, processo para preparar uma solução farmacêutica e método para tratamento
MX338657B (es) Dispositivo de osteosintesis con placa y pernos.
MX372747B (es) Uso de nuevas aminas para estabilizar trialquilalcanolaminas cuaternarias.
BR112014004246A2 (pt) unidade de corte e dispositivos, sistemas e métodos associados
BR112018014267A2 (pt) processo de preparação de etilenoaminas
BR112013028598A2 (pt) método para promover o crescimento de plantas
BRPI0913291A2 (pt) composto, pró-droga, medicamento, métodos para diminuir a proteína 4 ou tratamento de diabete em um mamífero, e, uso do composto
CY1115666T1 (el) Τραζοδονη και υδροχλωρικη τραζοδονη σε κεκαθαρμενη μορφη
BR112015014583B1 (pt) compostos, processo para a preparação de compostos, compostos intermediários, composição, usos de um composto de fórmula i e método para combater fungos nocivos
BR112014014762A8 (pt) método para preparação de cisteína ou de um derivado desta usando uma nova o-fosferina sulfidrilase
BR112015001655A2 (pt) método para purificar pelo menos uma saponina em uma solução, componente de produto de saponina qs-21 purificada, e, composição imunogênica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.